Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
British Journal of Haematology
|
November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantation
Xiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
Blood
|
June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?
Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.
Bone Marrow Transplantation
|
May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
Ying-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
JCI Insight
|
January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
Xing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
European Journal of Gastroenterology & Hepatology
|
December 4, 2025
Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort study
Xiao-Ling Xu, Jia-Yong Su, Yi Zhang, et al.
Human Immunology
|
June 12, 2018
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study
Ming-Rui Huo, Ya-Jing Xu, Shu-Zhen Zhai, et al.
The Lancet Regional Health. Western Pacific
|
January 8, 2026
Mapping the landscape of healthcare-associated infections in China, 2015-2019: a nation-wide observational study
Hong-Wu Yao, Chen-Long Lv, Yao Tian, et al.
Liver Cancer
|
June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Study
Da-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
British Journal of Haematology
|
November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantation
Xiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
Blood
|
June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?
Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.
Bone Marrow Transplantation
|
May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
Ying-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
JCI Insight
|
January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
Xing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
European Journal of Gastroenterology & Hepatology
|
December 4, 2025
Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort study
Xiao-Ling Xu, Jia-Yong Su, Yi Zhang, et al.
Human Immunology
|
June 12, 2018
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study
Ming-Rui Huo, Ya-Jing Xu, Shu-Zhen Zhai, et al.
The Lancet Regional Health. Western Pacific
|
January 8, 2026
Mapping the landscape of healthcare-associated infections in China, 2015-2019: a nation-wide observational study
Hong-Wu Yao, Chen-Long Lv, Yao Tian, et al.
Liver Cancer
|
June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Study
Da-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Page
of 15